| Host: |
Rabbit |
| Applications: |
DB/ELISA/IP/WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-PGAP3 (300-350) is suitable for use in Dot Blot, ELISA, Immunoprecipitation and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
FITC |
| Isotype: |
IgG |
| Purification: |
Affinity Purified |
| Concentration: |
0.50-0.75 µg/µl |
| Dilution Range: |
WB: 1:500-1:1, 000DB: 1:50, 000ELISA: 1:50, 000IP: 1:150 |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
PGAP3 |
| Gene ID: |
93210 |
| Uniprot ID: |
PGAP3_HUMAN |
| Immunogen Region: |
300-350 |
| Immunogen: |
Synthetic Peptide taken within amino acid region 300-350 on human PGAP3 protein. |
| Tissue Specificity | Ubiquitously expressed, with highest levels in thyroid and placenta. |
| Function | Involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchors proteins. Required for phospholipase A2 activity that removes an acyl-chain at the sn-2 position of GPI-anchors during the remodeling of GPI. |
| Protein Name | Post-Gpi Attachment To Proteins Factor 3Cos16 HomologHcos16Gene Coamplified With Erbb2 ProteinPer1-Like Domain-Containing Protein 1 |
| Cellular Localisation | Golgi Apparatus MembraneMulti-Pass Membrane ProteinEndoplasmic Reticulum MembraneMainly Localizes To Golgi Apparatus |
| Alternative Antibody Names | Anti-Post-Gpi Attachment To Proteins Factor 3 antibodyAnti-Cos16 Homolog antibodyAnti-Hcos16 antibodyAnti-Gene Coamplified With Erbb2 Protein antibodyAnti-Per1-Like Domain-Containing Protein 1 antibodyAnti-PGAP3 antibodyAnti-CAB2 antibodyAnti-PERLD1 antibodyAnti-UNQ546 antibodyAnti-PRO1100 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
